Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000176204 | SCV000227819 | likely benign | not specified | 2015-02-12 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000176204 | SCV000512809 | benign | not specified | 2015-04-30 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV000463939 | SCV000560869 | benign | Duchenne muscular dystrophy | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000619554 | SCV000736626 | likely benign | Cardiovascular phenotype | 2016-06-27 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
ARUP Laboratories, |
RCV003736621 | SCV004563241 | likely benign | not provided | 2023-09-28 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001826891 | SCV002089679 | likely benign | Becker muscular dystrophy; Duchenne muscular dystrophy; Cardiomyopathy; Dystrophin deficiency | 2017-04-20 | no assertion criteria provided | clinical testing |